The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Big FDA review coming this July. Here's what athletes and patients should know about BPC 157, TB 500, and the broader peptide conversation. Always speak with your physician before starting any new protocol. #bpc157 # Bioengineered corneal tissue for minimally invasive vision restoration in advanced keratoconus in two clinical cohorts Nature Biotechnology When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida